Susquehanna International Group, LLP Guardant Health, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $470,530 - $765,719	-21,100 Reduced 14.51%	124,300 $2.85 Million
Q2 2024 Aug 15, 2024	SELL	$16.07 - $31.84 $4.02 Million - $7.96 Million	-250,000 Reduced 63.23%	145,400 $4.2 Million
Q1 2024 May 07, 2024	BUY	$17.13 - $26.91 $5.59 Million - $8.78 Million	326,200 Added 471.39%	395,400 $8.16 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $416,493 - $569,350	-19,300 Reduced 21.81%	69,200 $1.87 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $1.12 Million - $1.74 Million	-43,500 Reduced 32.95%	88,500 $2.62 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $489,996 - $889,434	23,400 Added 21.55%	132,000 $4.73 Million
Q1 2023 May 16, 2023	SELL	$22.92 - $33.76 $1.82 Million - $2.69 Million	-79,600 Reduced 42.3%	108,600 $2.55 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $6.31 Million - $14.8 Million	-248,100 Reduced 56.86%	188,200 $5.12 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $12.8 Million - $17.9 Million	294,000 Added 206.61%	436,300 $23.5 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.